PHASE I-II INVESTIGATION OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS WITH SARCOMA RECEIVING HIGH-DOSE CHEMOTHERAPY (CT) WITH ADRIAMYCIN (A) AND IFOSFAMIDE (I)
S. Vadhanraj et al., PHASE I-II INVESTIGATION OF RECOMBINANT HUMAN THROMBOPOIETIN (RHTPO) IN PATIENTS WITH SARCOMA RECEIVING HIGH-DOSE CHEMOTHERAPY (CT) WITH ADRIAMYCIN (A) AND IFOSFAMIDE (I), Blood, 88(10), 1996, pp. 1779-1779